Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    This reflects a minor ClinicalTrials.gov site/UI release update (revision label changed to v3.5.3) without changing the study details themselves.
    Difference
    0.0%
    Check dated 2026-04-26T15:43:58.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:13:18.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Added Carcinosarcoma of the corpus uteri as an associated condition reference and included a link to the Genetic and Rare Diseases Information Center in the Resources section.
    Difference
    0.1%
    Check dated 2026-03-29T03:52:59.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:10:52.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A new site revision v3.4.3 was added and the previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-07T05:56:15.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.4.2) replacing the previous (v3.4.1). This appears to be a cosmetic version update.
    Difference
    0.0%
    Check dated 2026-02-13T12:38:37.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.